Developments in Toxicology Support for the DRE Community
•Télécharger en tant que PPT, PDF•
1 j'aime•1,400 vues
NMS Labs and Draeger Safety Diagnostics announce a partnership formed to deliver the Total Oral Fluid Drug Testing Solution. Presented by Barry K. Logan PhD, DABFT, National Director of Forensic Services, NMS Labs - July 2011..
![[object Object],[object Object],Welcome](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)
Recommandé
Recommandé
Contenu connexe
Tendances
Tendances (20)
En vedette
En vedette (20)
Similaire à Developments in Toxicology Support for the DRE Community
Similaire à Developments in Toxicology Support for the DRE Community (20)
Plus de NMS Labs
Plus de NMS Labs (12)
Dernier
Dernier (20)
Developments in Toxicology Support for the DRE Community
- 1. DEVELOPMENTS IN TOXICOLOGY SUPPORT FOR THE DRE COMMUNITY Barry K Logan PhD, DABFT National Director of Forensic Services NMS Labs
- 3. Oral Fluid Drug Testing for DRE
- 8. DUID Oral Fluid Use Belgium: saliva screening, blood/saliva confirmation Australia: saliva screening (2x), saliva confirmation Germany: saliva/urine testing, blood confirmation UK: FST, blood sampling; no device being used France: saliva screening, blood confirmation Switzerland: Approved for use
- 9. DUID Oral Fluid Use OF Specifically Approved in: Alabama Arizona Colorado Indiana Kansas Louisiana Missouri New York North Carolina North Dakota Ohio Oregon South Dakota Utah
- 18. Designer Drugs and Synthetics
- 24. Syn Cann: DRE Case State College, PA Driving Male, 21 yo Five hits “Mr Nice Guy Incense” two hours prior, in a blunt Admits 20mg Zyprexa one hour prior Minor one car crash into curb Toxicology (Blood) Behavioral Olanzapine JWH-018 10ng/mL 5ng/mL Subject has slurred speech, slow and low Unsteady on feet States he can hardly stand Fell asleep during evaluation Eyes rolled back in his head Poor coordination Cooperative DRE Opinion CNS Depressant/Cannabis
- 25. Syn Cann: DRE Case State College, PA Physiological Male, 21 yo Five hits “Mr Nice Guy Incense” two hours prior, in a blunt Admits 20mg Zyprexa one hour prior HGN VGN LOC Pulse BP Eyes Pupil size Temp. All six clues, immediate onset Present Present 86 BPM 108/54 Bloodshot Dilated 101 Toxicology (Blood) SFST Olanzapine JWH-018 10ng/mL 5ng/mL OLS Unable to perform WAT Unable to perform DRE Opinion CNS Depressant/Cannabis FTN Unable to perform
- 28. Thank You! www.NMSLabs.com www.draeger.com
- 29. DRE Immunoassay Panel For each of the immunoassay tests run, how often are they positive? Immunoassay Positivity Rate (%) (n=3810 cases) Amphetamines 5.3 Barbiturates 0.2 Benzodiazepines 21.4 Cocaine/Metabolites 11.0 Methadone 3.7 Opiates 13.7 PCP 1.2 Propoxyphene* 0.4 Cannabinoids 47.3
- 30. DRE Immunoassay Panel For each of the immunoassay test positives, how often are the confirmations negative? Reflex test All Negative Rate (%) Amphetamines 41.5 Barbiturates 14.5 Benzodiazepines 7.2 Cocaine/Metabolites 24.5 Methadone 8.8 Opiates 15.5 PCP 24.5 Propoxyphene* 23.2 Cannabinoids 42.1
- 31. DRE Immunoassay Panel For each of the immunoassay tests run, how often are they positive? Immunoassay Positivity Rate (%) (n=3810 cases) Amphetamines 5.3 Barbiturates 0.2 Benzodiazepines 21.4 Cocaine/Metabolites 11.0 Methadone 3.7 Opiates 13.7 PCP 1.2 Propoxyphene* 0.4 Cannabinoids 47.3
Notes de l'éditeur
- Henderson (1986) first described a synthetic drug as one which was designed by a clandestine chemist to produce a certain pharmacological response.
- Henderson (1986) first described a synthetic drug as one which was designed by a clandestine chemist to produce a certain pharmacological response.
- Henderson (1986) first described a synthetic drug as one which was designed by a clandestine chemist to produce a certain pharmacological response.
- Henderson (1986) first described a synthetic drug as one which was designed by a clandestine chemist to produce a certain pharmacological response.